Platinum-refractory oral cancers could have a poorer therapeutic response to immunotherapy than their non-oral counterparts

K. Devaraja

doi:10.4103/crst.crst_307_22

Platinum-refractory oral cancers could have a poorer therapeutic response to immunotherapy than their non-oral counterparts

K. Devaraja^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	779-780
Number of pages	2
Journal	Cancer Research, Statistics, and Treatment
Volume	5
Issue number	4
DOIs	https://doi.org/10.4103/crst.crst_307_22
Publication status	Published - 01-10-2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Ophthalmology
Drug guides
Oncology(nursing)
Cancer Research

Access to Document

10.4103/crst.crst_307_22

Cite this

@article{cd3eeba2fc6a427287e097c92c4bac2b,

title = "Platinum-refractory oral cancers could have a poorer therapeutic response to immunotherapy than their non-oral counterparts",

author = "K. Devaraja",

year = "2022",

month = oct,

day = "1",

doi = "10.4103/crst.crst\_307\_22",

language = "English",

volume = "5",

pages = "779--780",

journal = "Cancer Research, Statistics, and Treatment",

issn = "2590-3233",

publisher = "Wolters Kluwer Medknow Publications",

number = "4",

}

TY - JOUR

T1 - Platinum-refractory oral cancers could have a poorer therapeutic response to immunotherapy than their non-oral counterparts

AU - Devaraja, K.

PY - 2022/10/1

Y1 - 2022/10/1

UR - https://www.scopus.com/pages/publications/85151012604

UR - https://www.scopus.com/pages/publications/85151012604#tab=citedBy

U2 - 10.4103/crst.crst_307_22

DO - 10.4103/crst.crst_307_22

M3 - Letter

AN - SCOPUS:85151012604

SN - 2590-3233

VL - 5

SP - 779

EP - 780

JO - Cancer Research, Statistics, and Treatment

JF - Cancer Research, Statistics, and Treatment

IS - 4

ER -

Platinum-refractory oral cancers could have a poorer therapeutic response to immunotherapy than their non-oral counterparts

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this